Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 25;7(2):e839.
doi: 10.1097/HS9.0000000000000839. eCollection 2023 Feb.

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel

Naama Yekutiel  1 , Gabriel Chodick  1   2 , Lilac Tene  1 , Yotam Bronstein  3 , Moshe Grunspan  4 , Noa Rivlin  4 , Keren Ofek  4 , Raanan Cohen  4 , Leon Raskin  5 , Viktor Komlosi  5 , Yair Herishanu  2   3
Affiliations

COVID-19 Breakthrough Infections in Vaccinated Patients With CLL in Israel

Naama Yekutiel et al. Hemasphere. .
No abstract available

PubMed Disclaimer

References

    1. Chatzikonstantinou T, Kapetanakis A, Scarfò L, et al. . COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia. 2021;35:3444–3454. - PMC - PubMed
    1. Forconi F, Moss P. Perturbation of the normal immune system in patients with CLL. Blood. 2015;126:573–581. - PubMed
    1. Herishanu Y, Avivi I, Aharon A, et al. . Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137:3165–3173. - PMC - PubMed
    1. Herishanu Y, Rahav G, Levi S, et al. . Efficacy of a third BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL who failed standard 2-dose vaccination. Blood. 2022;139:678–685. - PMC - PubMed
    1. Polack FP, Thomas SJ, Kitchin N, et al. . Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed